DermAb.io
Haifa, Israel
DermAb.io is developing a clinical decision support system for prescribing personalized biologic therapies. Our non-invasive technology retrieves biomarkers painlessly from the skin’s surface. Our tool provides the predictive value for physicians to prescribe the most effective biological medication right away. The trial and error method applied today can add a cost of $8000 per patient, and extend the patient’s pain for months. The DermAb.io platform will significantly shorten the time to reach a proper treatment regimen, reducing costs and patients’ suffering.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2022
- Website
- dermab.io/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of DermAb.io?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now